StonvexLoading…
StonvexStonvexStonvexCore line items from ASST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-09-11 |
|---|---|---|---|---|
Revenue | $2.76M | $1.51M | $255.00K | $4.22M |
Operating Income | $-313.15M | $-241.14M | $-44.09M | $-11.86M |
Net Income | $-265.91M | $-393.60M | $-192.29M | $-26.99M |
EPS (Diluted) | $-4.53 | $-9.04 | $-0.22 | $-11.74 |
Total Assets | $1.10B | $745.53M | $792.58M | Not available |
Total Liabilities | $26.31M | $14.29M | $13.15M | Not available |
Cash & Equivalents | $95.09M | $67.50M | $109.07M | $3.92M |
Free Cash Flow OCF − CapEx | $-30.99M | $-24.99M | $-13.96M | $-18.21M |
Shares Outstanding | 61.63M | 44.00M | 872.35M | 2.30M |